745MO Raludotatug deruxtecan (R-DXd; DS-6000) monotherapy in patients with previously treated ovarian cancer (OVC): Subgroup analysis of a first-in-human phase I study
Kathleen N. Moore, Alexander Philipovskiy, Kenichi Harano, Brian I. Rini, Kazuki Sudo, Shigehisa Kitano, David R. Spigel, W. Marston Linehan, Mondira Kundu, Amine Bensmaine, Yusuke Myobatake, E.P. Hamilton
Topics & Concepts
MedicineTolerabilityInternal medicineAdverse effectTaxaneOvarian cancerGastroenterologyPhases of clinical researchOncologyCancerChemotherapyBreast cancerHER2/EGFR in Cancer ResearchOvarian cancer diagnosis and treatmentMonoclonal and Polyclonal Antibodies Research